Thanks very much to everyone who took the time to participate in our September poll, which asked your preferred method for keeping up to date with the Mental Elf. Half of those who voted said that a weekly email newsletter would be the best way to keep up to date. Visiting the website was quite [read the full story…]
Last week I blogged about a study that showed how some dementia drugs may help reduce the progression of the disease and delay admission to care homes for people with the condition. This new systematic review carried out by a research team from Harvard Medical School investigates the potential side effects of two dementia drugs: [read the full story…]
Prescribing anti-dementia drugs to patients could help delay their admission to care homes, according to a new study published in the October issue of The Psychiatrist. Psychiatrists Dr Emad Salib and Dr Jessica Thompson studied a total of 339 people with dementia, who were referred to psychiatric services in Peasley Cross Hospital in St Helens [read the full story…]
The Royal College of Psychiatrists has today published a new report into the mental health of students in higher education. The report calls for more investment in mental health support for university students, amid concerns that some students with mental health problems may be missing out on the help they need. The College published its [read the full story…]
This week’s British Medical Journal features a review of depression in later life. The authors bring together recent systematic reviews, meta-analyses, and randomised controlled trials to summarise best current knowledge about the diagnosis and management of patients who develop depression in later life. The review addresses the following questions: What is late life depression and [read the full story…]
We know that many people who take antipsychotic drugs find it difficult to cope with the side effects of the medication and this often leads to them stopping their treatment. This large Finish cohort study examines the risks of rehospitalisation and drug discontinuation in patients recently diagnosed with schizophrenia who have been prescribed antipsychotics. The [read the full story…]
End-of-life care services are typically funded and delivered by a mix of organisations from the NHS, local authorities and the voluntary sector as well as by independent agencies and through individual means (informal or family carers). Given the growing complexity of and demands on end-of-life care services, commissioning in this area is likely to be [read the full story…]
The evidence-base for psychodynamic psychotherapy is growing. A meta-analysis by Shedler published in early 2010 showed that the effect sizes for psychodynamic therapy can be as large as for other ’empirically supported treatments’. However, there are fewer high quality studies available that look at the effectiveness of these therapies for young people. This systematic review [read the full story…]
Benzodiazepines are most commonly prescribed for the management of anxiety and insomnia. They can also be used for sedation or amnesia before medical or surgical procedures, treatment of seizure, treatment of alcohol or sedative withdrawal, or acute agitation. Known side effects include drowsiness, fatigue and ataxia (the loss of full control of bodily movements). Opioids [read the full story…]
Research shows that using antidepressants (serotonin reuptake inhibitors, SRIs) to treat obsessive compulsive disorder (OCD) in young people is sometimes problematic. Patients often do not respond to the drugs and so other therapies are necessary to augment the treatment. One such therapy is CBT (cognitive behavioural therapy). This 12-week randomised controlled trial took 124 paediatric [read the full story…]
